Published in Gut on June 01, 2003
Prospective Evaluation of PleurX Drain for Treatment of Cirrhotic Refractory Ascites | NCT04569565
Predictive indices of morbidity and mortality after liver resection. Ann Surg (2006) 2.01
Important predictor of mortality in patients with end-stage liver disease. Clin Mol Hepatol (2013) 1.15
Clinical relevance of sarcopenia in patients with cirrhosis. World J Gastroenterol (2014) 1.03
H-graft portacaval shunts versus TIPS: ten-year follow-up of a randomized trial with comparison to predicted survivals. Ann Surg (2005) 0.99
MELD vs Child-Pugh and creatinine-modified Child-Pugh score for predicting survival in patients with decompensated cirrhosis. World J Gastroenterol (2005) 0.98
Transjugular intrahepatic portosystemic shunt-related complications and practical solutions. Semin Intervent Radiol (2006) 0.97
A prediction model for COPD readmissions: catching up, catching our breath, and improving a national problem. J Community Hosp Intern Med Perspect (2012) 0.93
Predictive factors for rebleeding and death in alcoholic cirrhotic patients with acute variceal bleeding: a multivariate analysis. World J Surg (2009) 0.93
Child-Pugh-Turcott versus Meld score for predicting survival in a retrospective cohort of black African cirrhotic patients. World J Gastroenterol (2008) 0.92
Relationship of hemodynamic indices and prognosis in patients with liver cirrhosis. Korean J Intern Med (2004) 0.92
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of survival and metastasis for recurrent hepatocellular carcinoma after transarterial chemoembolization. PLoS One (2015) 0.92
Child-Pugh Versus MELD Score for the Assessment of Prognosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis of Observational Studies. Medicine (Baltimore) (2016) 0.90
Value of portal hemodynamics and hypersplenism in cirrhosis staging. World J Gastroenterol (2005) 0.90
Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications. World J Gastroenterol (2014) 0.88
Serum hyaluronate level for predicting subclinical liver dysfunction after hepatectomy. World J Surg (2004) 0.88
Alkaline phosphatase: the next independent predictor of the poor 90-day outcome in alcoholic hepatitis. Biomed Res Int (2013) 0.86
TIPS versus peritoneovenous shunt in the treatment of medically intractable ascites: a prospective randomized trial. Ann Surg (2004) 0.86
Transjugular intrahepatic porto-systemic shunt in the elderly: Palliation for complications of portal hypertension. World J Hepatol (2012) 0.85
Using transjugular intrahepatic portosystemic shunts for complications of cirrhosis. Clin Gastroenterol Hepatol (2011) 0.85
New model for end stage liver disease improves prognostic capability after transjugular intrahepatic portosystemic shunt. Clin Gastroenterol Hepatol (2009) 0.83
Prediction of mortality after emergent transjugular intrahepatic portosystemic shunt placement: use of APACHE II, Child-Pugh and MELD scores in Asian patients with refractory variceal hemorrhage. Korean J Radiol (2009) 0.83
Role of TIPS in Improving Survival of Patients with Decompensated Liver Disease. Int J Hepatol (2011) 0.83
Combined MELD and blood lipid level in evaluating the prognosis of decompensated cirrhosis. World J Gastroenterol (2010) 0.82
Transjugular Intrahepatic Porto-Systemic Shunt in Patients with Liver Cirrhosis and Model for End-Stage Liver Disease ≥15. Dig Dis Sci (2016) 0.81
Transjugular intrahepatic portosystemic shunt in the management of refractory ascites. Semin Intervent Radiol (2005) 0.80
Role of emergency transjugular intrahepatic portosystemic shunts. Semin Intervent Radiol (2005) 0.80
Child-Na score: a predictive model for survival in cirrhotic patients with symptomatic portal hypertension treated with TIPS. PLoS One (2013) 0.80
Predicting Mortality Across a Broad Spectrum of Liver Disease-An Assessment of Model for End-Stage Liver Disease (MELD), Child-Turcotte-Pugh (CTP), and Creatinine-Modified CTP Scores. J Clin Exp Hepatol (2012) 0.78
Use of the Model for End-Stage Liver Disease (MELD) score to predict 1-year survival of Japanese patients with cirrhosis and to determine who will benefit from living donor liver transplantation. J Gastroenterol (2008) 0.78
Behavior of Oxidative Stress Markers in Alcoholic Liver Cirrhosis Patients. Oxid Med Cell Longev (2016) 0.78
Quantification of hepatic blood flow using a high-resolution phase-contrast MRI sequence with compressed sensing acceleration. AJR Am J Roentgenol (2015) 0.77
The evaluation of the patient undergoing an elective transjugular intrahepatic portosystemic shunt procedure. Semin Intervent Radiol (2005) 0.77
Application of a biochemical and clinical model to predict individual survival in patients with end-stage liver disease. World J Gastroenterol (2009) 0.77
Peritoneal Dialysis is Associated With A Better Survival in Cirrhotic Patients With Chronic Kidney Disease. Medicine (Baltimore) (2016) 0.76
Comparison of Cox's Regression Model and Parametric Models in Evaluating the Prognostic Factors for Survival after Liver Transplantation in Shiraz during 2000-2012. Int J Organ Transplant Med (2015) 0.75
QT prolongation is associated with increased mortality in end stage liver disease. World J Cardiol (2017) 0.75
Circulating insulin-like growth factor-binding protein 3 as prognostic biomarker in liver cirrhosis. World J Hepatol (2016) 0.75
Comparison of the ability of the PDD-ICG clearance test, CTP, MELD, and MELD-Na to predict short-term and medium-term mortality in patients with decompensated hepatitis B cirrhosis. Eur J Gastroenterol Hepatol (2016) 0.75
Transjugular intrahepatic portosystemic shunts in patients with hepatic malignancy. Semin Intervent Radiol (2005) 0.75
Management of cirrhotic ascites. Ther Adv Chronic Dis (2015) 0.75
Platelet count combined with right liver volume and spleen volume measured by magnetic resonance imaging for identifying cirrhosis and esophageal varices. World J Gastroenterol (2015) 0.75
Nationwide trends and predictors of inpatient mortality in 83884 transjugular intrahepatic portosystemic shunt. World J Gastroenterol (2016) 0.75
HbA1c-Based Score Model for Predicting Death Risk in Patients with Hepatocellular Carcinoma and Type 2 Diabetes Mellitus. J Diabetes Res (2017) 0.75
Predictive accuracy comparison of MELD and Child-Turcotte-Pugh scores for survival in patients underwent TIPS placement: a systematic meta-analytic review. Int J Clin Exp Med (2015) 0.75
"Neo-PIRO": Introducing a Novel Grading System for Surgical Infections of Neonates. J Indian Assoc Pediatr Surg (2017) 0.75
Survival in Cirrhotic Patients with High MELD Scores: The TIPping Point. Dig Dis Sci (2016) 0.75
Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics (1988) 70.41
Transection of the oesophagus for bleeding oesophageal varices. Br J Surg (1973) 26.26
A model to predict survival in patients with end-stage liver disease. Hepatology (2001) 18.06
A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology (2000) 9.74
Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology (1996) 4.54
MELD and PELD: application of survival models to liver allocation. Liver Transpl (2001) 3.76
The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl (2002) 3.44
The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med (1994) 3.01
Compensated cirrhosis: natural history and prognostic factors. Hepatology (1987) 3.01
The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med (1995) 2.21
A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med (2000) 2.20
Prognostic value of Child-Turcotte criteria in medically treated cirrhosis. Hepatology (1984) 1.95
Predicting the prognosis of chronic liver disease: an evolution from child to MELD. Mayo End-stage Liver Disease. Hepatology (2001) 1.94
Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients. Radiology (1993) 1.92
Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Gastroenterology (1995) 1.81
Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage. Am J Gastroenterol (1997) 1.80
Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics. Hepatology (1987) 1.78
Superiority of the Child-Pugh classification to quantitative liver function tests for assessing prognosis of liver cirrhosis. Scand J Gastroenterol (1989) 1.72
Assessment of the validity of the INR system for patients with liver impairment. Thromb Haemost (1994) 1.63
Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding. Lancet (1997) 1.47
A peek at the Child-Turcotte classification. Hepatology (1982) 1.34
Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio? Hepatology (1996) 1.28
The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): state of the art. Liver (1998) 1.23
Serum bilirubin and early mortality after transjugular intrahepatic portosystemic shunts: results of a multivariate analysis. J Vasc Interv Radiol (2002) 1.18
Transjugular intrahepatic portosystemic shunt for treatment of portal hypertension due to extramedullary hematopoiesis in idiopathic myelofibrosis. Blood (2002) 1.12
Critical appraisal of the angiographic portacaval shunt (TIPS). Am J Surg (1993) 1.01
Interpretation of the international normalised ratio in patients with liver disease. Lancet (2002) 1.01
A prognostic model for patients with end-stage liver disease. Gastroenterology (1997) 0.99
Plasma renin activity and urinary sodium excretion as prognostic indicators in nonazotemic cirrhosis with ascites. Ann Intern Med (1981) 0.96
Repeat interventions for maintenance of transjugular intrahepatic portosystemic shunt function in patients with Budd-Chiari syndrome. J Vasc Interv Radiol (2002) 0.96
Routine tests of renal function, alcoholism, and nutrition improve the prognostic accuracy of Child-Pugh score in nonbleeding advanced cirrhotics. Am J Gastroenterol (1993) 0.93
Prognostic evaluation of patients with parenchymal cirrhosis. Proposal of a new simple score. J Hepatol (1997) 0.92
Primary implantation of polyester-covered stent-grafts for transjugular intrahepatic portosystemic stent shunts (TIPSS): A pilot study. Cardiovasc Intervent Radiol (1999) 0.91
Aminopyrine breath test in the prognostic evaluation of patients with cirrhosis. Gut (1992) 0.90
Precision and accuracy of the international normalized ratio in oral anticoagulant control. Haemostasis (1996) 0.89
Child comes of age. Hepatology (2002) 0.88
The mechanism of the initial natriuresis after transjugular intrahepatic portosystemic shunt. Gastroenterology (1997) 0.88
Prognostic value of total serum bilirubin/gamma-glutamyl transpeptidase ratio in cirrhotic patients. Hepatology (1984) 0.84
The use and misuse of transjugular intrahepatic portasystemic shunts. Curr Gastroenterol Rep (2000) 0.83
Validity of the INR system for patients with liver impairment. Thromb Haemost (1995) 0.82
Monoethylglicinexylidide test: a prognostic indicator of survival in cirrhosis. Hepatology (1994) 0.81
Prognostic value of the intravenous 14C-aminopyrine breath test compared to the Child-Pugh score and serum bile acids in 84 cirrhotic patients. Digestion (1991) 0.78
[Transjugular intrahepatic portosystemic shunt (TIPS)]. Wien Klin Wochenschr (2000) 0.78
Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature (2000) 18.26
A classification of chronic hepatitis. Lancet (1968) 6.07
A cytoplasmic 57-kDa protein that is required for translation of picornavirus RNA by internal ribosomal entry is identical to the nuclear pyrimidine tract-binding protein. Proc Natl Acad Sci U S A (1993) 4.71
Functional mammalian homologues of the Drosophila PEV-modifier Su(var)3-9 encode centromere-associated proteins which complex with the heterochromatin component M31. EMBO J (1999) 4.34
Endoluminal stent-grafts for infrarenal abdominal aortic aneurysms. N Engl J Med (1997) 4.26
Combined molecular and conventional analyses of nitrifying bacterium diversity in activated sludge: Nitrosococcus mobilis and Nitrospira-like bacteria as dominant populations. Appl Environ Microbiol (1998) 4.23
Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature (2000) 3.81
Physical and genetic mapping of a novel chromosome 19 ERCC1 marker showing close linkage with myotonic dystrophy. Genomics (1991) 3.72
Polymorphisms of interferon-λ4 and IL28B - effects on treatment response to interferon/ribavirin in patients with chronic hepatitis C. Aliment Pharmacol Ther (2013) 3.59
Wilson's disease in patients presenting with liver disease: a diagnostic challenge. Gastroenterology (1997) 3.52
Prevalence of flat lesions in a large screening population and their role in colonoscopy quality improvement. Endoscopy (2013) 2.72
Primary gastric B-cell lymphoma: results of a prospective multicenter study. The German-Austrian Gastrointestinal Lymphoma Study Group. Gastroenterology (2000) 2.65
Isolation and characterization of Suv39h2, a second histone H3 methyltransferase gene that displays testis-specific expression. Mol Cell Biol (2000) 2.56
The expression of a truncated HMGI-C gene induces gigantism associated with lipomatosis. Cancer Res (1999) 2.56
Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study. Gut (2006) 2.53
Gross chromosomal rearrangements and genetic exchange between nonhomologous chromosomes following BRCA2 inactivation. Genes Dev (2000) 2.47
The association between self-reported symptoms of asthma and allergic rhinitis and self-reported traffic density on street of residence in adolescents. Epidemiology (1996) 2.44
Primary interferon resistance and treatment response in chronic hepatitis C infection: a pilot study. Lancet (2001) 2.40
ADSORB: a study on the efficacy of endovascular grafting in uncomplicated acute dissection of the descending aorta. Eur J Vasc Endovasc Surg (2012) 2.35
Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties. J Mol Biol (2000) 2.34
Twice-weekly administration of peginterferon-alpha-2b improves viral kinetics in patients with chronic hepatitis C genotype 1. J Viral Hepat (2003) 2.33
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm. J Viral Hepat (2014) 2.23
Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group. Gastroenterology (2000) 2.23
Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group. Gastroenterology (2000) 2.21
Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases. J Neurol Neurosurg Psychiatry (2008) 2.16
Von Willebrand Factor as a new marker for non-invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C. Aliment Pharmacol Ther (2013) 2.12
Characteristics of polytrauma patients between 1992 and 2002: what is changing? Injury (2007) 2.12
ESPEN Guidelines on Enteral Nutrition: Liver disease. Clin Nutr (2006) 2.11
Amodiaquine induced agranulocytosis and liver damage. Br Med J (Clin Res Ed) (1986) 2.08
Nd:YAG laser with sapphire tip combined with balloon angioplasty in peripheral arterial occlusions. Long-term results. Circulation (1991) 2.06
13C-urea versus 14C-urea breath test: is there still a need for 14C-urea? Nucl Med Commun (1998) 2.06
Durability of SVR in chronic hepatitis C patients treated with peginterferon-α2a/ribavirin in combination with a direct-acting anti-viral. Aliment Pharmacol Ther (2013) 2.04
Epidemiology and clinical features of imported dengue fever in Europe: sentinel surveillance data from TropNetEurop. Clin Infect Dis (2002) 2.02
Postcremation diagnosis from an electric shaver. Lancet (2001) 2.02
A quantitative fluorescence-based microplate assay for the determination of double-stranded DNA using SYBR Green I and a standard ultraviolet transilluminator gel imaging system. Anal Biochem (1999) 1.94
Structure-function analysis of SUV39H1 reveals a dominant role in heterochromatin organization, chromosome segregation, and mitotic progression. Mol Cell Biol (2000) 1.93
Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases. Hepatology (2001) 1.92
Evaluation of a virtual endoscopy simulator for training in gastrointestinal endoscopy. Endoscopy (2002) 1.91
Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro. J Mol Biol (1999) 1.89
Visualization of N-acylhomoserine lactone-mediated cell-cell communication between bacteria colonizing the tomato rhizosphere. Appl Environ Microbiol (2001) 1.86
Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib. Aliment Pharmacol Ther (2011) 1.85
Map of 16 polymorphic loci on the short arm of chromosome 16 close to the polycystic kidney disease gene (PKD1). J Med Genet (1990) 1.83
EFG1 is a major regulator of cell wall dynamics in Candida albicans as revealed by DNA microarrays. Mol Microbiol (2003) 1.79
300 million years of conserved synteny between chicken Z and human chromosome 9. Nat Genet (1999) 1.78
Intussusceptive angiogenesis: its role in embryonic vascular network formation. Circ Res (2000) 1.77
[Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection]. Z Gastroenterol (2010) 1.76
Mitotic phosphorylation of SUV39H1, a novel component of active centromeres, coincides with transient accumulation at mammalian centromeres. J Cell Sci (2000) 1.76
Antibody to Mycoplasma pneumoniae in nasal secretions and sputa of experimentally infected human volunteers. Infect Immun (1973) 1.72
Gonosomal mosaicism in myotonic dystrophy patients: involvement of mitotic events in (CTG)n repeat variation and selection against extreme expansion in sperm. Am J Hum Genet (1994) 1.71
Chromosome topology in mammalian interphase nuclei. Exp Cell Res (1991) 1.70
Comparison of three separate antiadhesive barriers for intraperitoneal onlay mesh hernia repair in an experimental model. Br J Surg (2010) 1.69
Historical epidemiology of hepatitis C virus (HCV) in selected countries. J Viral Hepat (2014) 1.68
Strategies to manage hepatitis C virus (HCV) disease burden. J Viral Hepat (2014) 1.67
Nuclear targeting of incoming human foamy virus Gag proteins involves a centriolar step. J Virol (1997) 1.65
Detection of the His1069Gln mutation in Wilson disease by rapid polymerase chain reaction. Ann Intern Med (1997) 1.64
Blunted thrombopoietin response to interferon alfa-induced thrombocytopenia during treatment for hepatitis C. Hepatology (1998) 1.62
Early identification and isolation of inpatients at high risk for tuberculosis. Arch Intern Med (1994) 1.61
The pteridine binding site of brain nitric oxide synthase. Tetrahydrobiopterin binding kinetics, specificity, and allosteric interaction with the substrate domain. J Biol Chem (1994) 1.61
Measurement of Mycoplasma pneumoniae mycoplasmacidal antibody in human serum. J Immunol (1972) 1.61
Energy metabolism in acute and chronic renal failure. Am J Clin Nutr (1990) 1.60
Value of hepatic venous pressure gradient measurement before liver resection for hepatocellular carcinoma. Br J Surg (2011) 1.60
Follow-up in children with Joubert syndrome. Neuropediatrics (1997) 1.59
Studies with lectins on the surface carbohydrate structures of mycoplasma membranes. J Bacteriol (1974) 1.59
Isolation and phylogenetic analysis of bacteria with antimicrobial activities from the Mediterranean sponges Aplysina aerophoba and Aplysina cavernicola. FEMS Microbiol Ecol (2001) 1.58
Arsenic and noncirrhotic portal hypertension. Gastroenterology (1974) 1.57
Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma. Arthritis Rheum (1979) 1.57
Disulfide analysis reveals a role for macrophage migration inhibitory factor (MIF) as thiol-protein oxidoreductase. J Mol Biol (1998) 1.56
The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma--a pilot study. Aliment Pharmacol Ther (2011) 1.54
Conflicting results of ileoscopy and small bowel double-contrast barium examination in patients with Crohn's disease. Endoscopy (1998) 1.53
Gastric emptying and secretion of bile acids, cholesterol, and pancreatic enzymes during digestion. Duodenal perfusion studies in healthy subjects. Mayo Clin Proc (1974) 1.53
[Risk assessment in pain therapy]. Schmerz (2008) 1.52
5-Azacytidine-induced undercondensations in human chromosomes. Hum Genet (1984) 1.50
Wilson disease in two consecutive generations: an exceptional family. Am J Gastroenterol (2001) 1.50
Macrosomia: a new formula for optimized fetal weight estimation. Ultrasound Obstet Gynecol (2010) 1.48
Characteristics of intergenerational contractions of the CTG repeat in myotonic dystrophy. Am J Hum Genet (1994) 1.46
Fast and type-specific analysis of herpes simplex virus types 1 and 2 by rapid PCR and fluorescence melting-curve-analysis. Infection (2000) 1.46
Studies on dicistronic polioviruses implicate viral proteinase 2Apro in RNA replication. Virology (1993) 1.46
N-Allyl-derivative of clonidine, a substance with specific bradycardic action at a cardiac site. Naunyn Schmiedebergs Arch Pharmacol (1979) 1.45
Conserved synteny between the chicken Z sex chromosome and human chromosome 9 includes the male regulatory gene DMRT1: a comparative (re)view on avian sex determination. Cytogenet Cell Genet (2000) 1.45
Characterization of murine BATF: a negative regulator of activator protein-1 activity in the thymus. Eur J Immunol (2001) 1.45
Unexpectedly high frequency of antibody to Mycoplasma pneumoniae in human sera as measured by sensitive techniques. J Infect Dis (1977) 1.45
Hepatocellular carcinoma in Central Europe: prognostic features and survival. Gut (2001) 1.45
Long-term benefit of 1-year amiodarone treatment for persistent complex ventricular arrhythmias after myocardial infarction. Circulation (1993) 1.42
In vitro reconstructed human epithelia reveal contributions of Candida albicans EFG1 and CPH1 to adhesion and invasion. Microbiology (2002) 1.42
Quantitative determination of rDNA transcription units in vertebrate cells. Exp Cell Res (1991) 1.42
The response of GFR to amino acids differs between autosomal dominant polycystic kidney disease (ADPKD) and glomerular disease. Nephrol Dial Transplant (1992) 1.41